Ipsen to buy some Merrimack assets for about $1 billion
January 08, 2017 at 20:23 PM EST
Jan 8 (Reuters) - French drugmaker Ipsen SA said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc, including its pancreatic cancer treatment Onivyde, for about $1 billion.
